Connecticut Innovations Invests $14.3 Million in Early-Stage Companies in FY 2020 Q3
Deals leveraged more than $143 million in outside capital
Rocky Hill, Conn. – April 30, 2020 – Connecticut Innovations (CI), Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies, today announced that investments during the third quarter of its 2020 fiscal year totaled $14.3 million across 39 transactions.
During this past quarter, $6.3 million in CI investment went to biotechnology companies, and $8 million went to information technology companies. The investments leveraged an additional $134.3 million in outside capital.
“With another active investment quarter, Connecticut Innovations continues to support the growth of many early-stage companies and entrepreneurial activity across the state,” said David Wurzer, executive vice president and chief investment officer at Connecticut Innovations. “During this difficult time, we are more committed than ever to provide the support, resources and partnership these companies need to prosper.”
Connecticut Innovations’ venture capital portfolio includes investments in more than 150 companies throughout the state.
About Connecticut Innovations
Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. CI provides venture capital and strategic support for early-stage technology companies, financial support for innovation and collaboration, and connections to its well-established network of partners and professionals. For more information, please visit www.ctinnovations.com.